Metrika, SpectRx Launch Glycated Hemoglobin Tests For Diabetic OTC Use

Timeliness and accuracy of over-the-counter glycated hemoglobin test results are two competing factors that may determine market acceptance of Metrika's A1cNow and SpectRx' SimpleChoice - both slated to be on OTC shelves by year-end

More from Archive

More from Medtech Insight